SOMATOSTATIN ANTAGONIZES ANGIOTENSIN-II EFFECTS ON MESANGIAL CELL CONTRACTION AND GLOMERULAR-FILTRATION

被引:31
作者
GARCIAESCRIBANO, C
DIEZMARQUES, ML
GONZALEZRUBIO, M
RODRIGUEZPUYOL, M
RODRIGUEZPUYOL, D
机构
[1] HOSP UNIV PRINCIPE ASTURIAS, SECC NEFROL, ALCALA HENARES, E-28880 MADRID, SPAIN
[2] UNIV ALCALA DE HENARES, DEPT PHYSIOL & PHARMACOL, ALCALA DE HENARES, SPAIN
[3] UNIV ALCALA DE HENARES, DEPT MED, ALCALA DE HENARES, SPAIN
[4] UNIV ALCALA DE HENARES, NEPHROL SECT, ALCALA DE HENARES, SPAIN
关键词
D O I
10.1038/ki.1993.50
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The effects of somatostatin (ST) on the regulation of the glomerular filtration rate have not been extensively studied. The present experiments were designed to analyze this possible relationship. ST alone did not modify the planar cell surface area (PCSA) of cultured rat mesangial cells (CRMC), but it prevented and reversed the reduction in PCSA induced by 10 nm angiotensin II (Ang II) in a dose- and time-dependent manner. ST (1 mum) completely prevented and reversed the increase in the myosin light chain phosphorylation induced by 10 nm Ang II. Incubation with pertussis toxin (PT, 0.5 mug/ml) inhibited the effect of ST on the Ang II-dependent changes in PCSA, but this effect was not inhibited by the blockade of the vasodilatatory prostaglandins (indomethacin, 10 mum) or nitric oxide (L-N-methyl-arginine, 0.2 mm) synthesis. 2',5'-dideoxyadenosine (DDA, 0.1 mm), an adenylate cyclase blocker, and methylene blue (MB, 30 mum), a soluble guanylate cyclase blocker, did not interfere with the ST inhibitory effect on the Ang II-dependent reduction in PCSA of rat mesangial cells. ST also blocked the reduction in PCSA induced by phorbol myristate acetate (PMA, 300 nm). ST was also able to prevent and revert the Ang II dependent reduction in glomerular cross-sectional area of isolated rat glomeruli, also in a dose- and time-dependent fashion. Finally, intravenous administration of ST (200 ng/kg body wt as a bolus plus a continuous injection of 25 ng/min/kg body wt) partially blocked the reduction in GFR (measured as C(In)) and RPF (measured as C(PAH)) and the increase in filtration fraction induced by the intravenous administration of Ang II (1.7 mug/min/kg body wt) in anesthetized rats. In summary, these results suggest that ST could antagonize the renal actions of Ang II, increasing the GFR and RPF decreased by Ang II, and this effect could be dependent, at least partially, on a direct relaxing effect of ST on mesangial cells.
引用
收藏
页码:324 / 333
页数:10
相关论文
共 37 条
[1]  
ARRIBA G, 1988, J LAB CLIN MED, V111, P466
[2]   A MICROSPHERE STUDY ON THE EFFECTS OF SOMATOSTATIN AND SECRETIN ON REGIONAL BLOOD-FLOW IN ANESTHETIZED DOGS [J].
BECKER, RHA ;
SCHOLTHOLT, J ;
SCHOLKENS, BA ;
JUNG, W ;
SPETH, O .
REGULATORY PEPTIDES, 1982, 4 (06) :341-351
[3]   SOMATOSTATIN - OCCURRENCE IN URINARY-BLADDER EPITHELIUM AND RENAL TUBULES OF THE TOAD, BUFO-MARINUS [J].
BOLAFFI, JL ;
REICHLIN, S ;
GOODMAN, DBP ;
FORREST, JN .
SCIENCE, 1980, 210 (4470) :644-646
[4]   INTERACTION OF SOMATOSTATIN WITH PTH AND AVP - RENAL EFFECTS [J].
BRAUTBAR, N ;
LEVINE, BS ;
COBURN, JW ;
KLEEMAN, CR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 237 (05) :E428-E431
[5]   MECHANISM OF CELLULAR EFFECT OF PHORBOL ESTERS ON ACTION OF ARGININE VASOPRESSIN AND ANGIOTENSIN-II ON RAT VASCULAR SMOOTH-MUSCLE CELLS IN CULTURE [J].
CARAMELO, C ;
TSAI, P ;
SCHRIER, RW .
BIOCHEMICAL JOURNAL, 1988, 254 (03) :625-629
[6]   CHRONIC ESTROGEN-TREATMENT REDUCES ANGIOTENSIN-II RECEPTORS IN THE ANTERIOR-PITUITARY [J].
CHEN, FCM ;
PRINTZ, MP .
ENDOCRINOLOGY, 1983, 113 (04) :1503-1510
[7]   SOMATOSTATIN - A METABOLIC REGULATOR [J].
DILEEPAN, KN ;
WAGLE, SR .
LIFE SCIENCES, 1985, 37 (25) :2335-2343
[8]   EFFECTS OF REACTIVE OXYGEN SPECIES ON CULTURED RAT MESANGIAL CELLS AND ISOLATED RAT GLOMERULI [J].
DUQUE, I ;
GARCIAESCRIBANO, C ;
RODRIGUEZPUYOL, M ;
DIEZMARQUES, ML ;
LOPEZNOVOA, JM ;
ARRIBAS, I ;
HERNANDO, L ;
RODRIGUEZPUYOL, D .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :F466-F473
[9]  
ENGLER M, 1991, KIDNEY INT, V39, P1301
[10]  
FARAH AE, 1983, PHARMACOL REV, V35, P181